Dr Emily Allen-Benton

Industry Partnerships and Commercialisation Officer, Medicine

Emily is an IPC Officer within the Faculty of Medicine team focussed on intellectual property management, supporting Imperial academics with commercial engagement, fostering collaborative research and negotiating out-licenses. Emily manages an IP portfolio which included the Faculty of Medicine Quicktech portfolio, comprising mouse models and other research tools.

Emily holds a PhD in Chemistry focussed on the sub-field of Synthetic Biology and has prior experience in the scientific publishing industry.

Emily's portfolio

The Benzodiazepine withdrawal symptom questionnaire (BWSQ)

The Benzodiazepine withdrawal symptom questionnaire (BWSQ)

BWSQ is the leading tool for assessing benzodiazepine withdrawal symptoms, used in a number of clinical trials involving benzodiazepines. Find out more

Portfolio of human colorectal adenocarcinomas

Portfolio of human colorectal adenocarcinomas

A portfolio of human colorectal adenocarcenoma cell lines including primary cell lines isolated from patients (of various Duke's stages and histological grades) in addition to cloned cells lines genetically modified to highly express alpha integrin domains. Find out more

MyoLoop for cardiovascular research

MyoLoop for cardiovascular research

MyoLoop is a device that can simulate pathological conditions (e.g. hypertension), to study their progression, and the effects of therapeutic interventions on them. Find out more

Charcot-Marie Tooth Disease model

Charcot-Marie Tooth Disease model

Proposed use Research into Charcot-Marie Tooth Disease (Type 1A). Research into autoimmune neurological disorders would be the main ... Find out more

Deep learning cardiac motion analysis for risk stratification of adverse cardiac event

Deep learning cardiac motion analysis for risk stratification of adverse cardiac event

A tool for predicting risk profile in patients with pre-existing cardiac dysfunction with greater accuracy than the current gold standard. Find out more

Improved Mycobacterial Tetracycline Inducible Vectors

Improved Mycobacterial Tetracycline Inducible Vectors

A range of improved tetracycline inducible vectors to study the function of essential mycobacterial genes. Find out more

Complement Factor H Knock Out Mouse Model

Complement Factor H Knock Out Mouse Model

In the field of eye disease, such as age-related macular degeneration (AMD) this mouse model has been proven important for research into the mechanisms of disease. This disease model is useful for conditions in which complement factor H plays a role. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...